Fortrea Holdings Inc
Fortrea Holdings Inc (FTRE) Historical Volatility
FTRE's 30 day historical volatility is 66.13%, in the 63rd percentile of readings over the past year. This is an average percentile, meaning Fortrea Holdings Inc shares have moved roughly in line with their typical range. FTRE's 30 day implied volatility sits at 78.36%, with an IV Rank of 17.46%, leaving IV 12.23 points above historical volatility. This means options are pricing in more movement than the stock has actually delivered, as of Nov 18, 2026.
Read more
Tracking FTRE historical volatility helps you see how much Fortrea Holdings Inc's stock price has actually moved, giving you a baseline for whether option premiums look fair, cheap, or expensive. While implied volatility shows what the market expects, FTRE's HV, also known as realized volatility, shows what actually happened. Use our scanner to monitor FTRE 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.
Historical volatility is the annualized standard deviation of a stock's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. FTRE's 30 day historical volatility, or FTRE HV, is one of the most widely watched readings because it balances responsiveness with stability. Comparing FTRE's HV to its implied volatility reveals the volatility risk premium. When IV sits well above HV, options are pricing in more movement than the stock has actually delivered, giving option sellers an edge. When HV runs hot relative to IV, options are pricing in less movement than the stock has delivered, and buyers may be underpaying for it.
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures.
Historical Volatility
Historical movement is near its typical level for the past year. Neither unusually calm nor unusually active.
As of Nov 18, 2026
As of Nov 18, 2026
As of Nov 18, 2026